- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03920930
Optimization of a Fast-track Concept for Knee Joint Replacement (KneeOptOut2)
Optimization of a Fast-track Concept for Knee Replacement: A Single-blind, Randomized, Controlled Clinical Trial
In an estimated 150,000 patients, a knee joint replacement is performed in Germany every year. The perioperative care of the patients aims at an optimal surgical technique, which leads to a high functionality in the joint, and above all at an adequate pain treatment. Patients experience pain especially intraoperatively and in the first days after the operation. The intensity of pain is a decisive factor that can hinder the patient's mobilization. In the KneeOptOut study (ethics application number EA4/009/17), which has already been successfully carried out and approved by this ethics committee, it was shown that the use of local infiltration anaesthesia (LIA) for pain therapy after primary knee endoprosthetics is comparable to catheter-supported regional anaesthesia (manuscript under review at the European Journal of Anaesthesiology). During surgery, the morphine requirement of patients in the LIA group was significantly higher than that of patients who underwent catheterization. Postoperatively, however, both subjective pain by VAS and opiate consumption were comparable.
In order to optimize the intraoperative opiate need/consumption, an early-intraoperative procedure for local infiltration anesthesia will now be compared with the previous late-intraoperative procedure. Both procedures correspond to SOP for the treatment of primary knee endoprostheses and are currently used depending on the surgeon's requirements.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 10117
- Charité - Universitätsmedizin Berlin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• patients undergoing elective, primary knee joint replacement in combined general anaesthesia
Exclusion Criteria:
- heart insufficiency NYHA >2
- liver insufficiency > CHILD B
- evidence of diabetic polyneuropathy
- severe adipositas BMI >40
- patients < 18 years
- pregnancy
- in case of police custody
- participation in a paralleled interventional RCT in a time frame of 30 days
- chronic opioid therapy >3 months before scheduled surgery
- allergy against medication required for surgery or anaesthesia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Early-intraoperative Local infiltration technique
A distal regional anaesthesia is performed in which the nerves are blocked by a local anaesthetic in the tissue in the immediate vicinity of the operating area ("tissue infiltration technique").
The LIA is applied in a total of 4 steps during the preparation of the knee joint: 1. after the skin incision, 2. after the capsule incision, 3. after complete exposure of the knee joint, 4. when the posterior knee capsule is reached.
|
The local infiltration analgesia is applied in a total of 4 steps during the preparation of the knee joint: 1. after the skin incision, 2. after the capsule incision, 3. after complete exposure of the knee joint, 4. when the posterior knee capsule is reached.
Other Names:
|
|
ACTIVE_COMPARATOR: Late-intraoperative Local infiltration technique
A distal regional anaesthesia is performed in which the nerves are blocked by a local anaesthetic in the tissue in the immediate vicinity of the operating area ("tissue infiltration technique").
The LIA is applied after the preparation of the femur and tibia bone shortly before the prosthesis is inserted and during the retreat from the knee joint.
|
Patient receive an infiltration of local anaesthetics around the knee directly after total knee replacement for postoperative pain control.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Opioid consumption
Time Frame: intraoperative, up to 3 hours
|
amount of opioids administered intraoperative measured as equivalent dose to morphin
|
intraoperative, up to 3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patients satisfaction (11-point likert scale)
Time Frame: up to 7 days postoperatively
|
global satisfaction of patients
|
up to 7 days postoperatively
|
|
time to first mobilisation (walking)
Time Frame: up to 7 days postoperatively
|
time from end of surgery until patients is able to walk
|
up to 7 days postoperatively
|
|
time to achieve full joint mobility
Time Frame: up to 7 days postoperatively
|
time to achieve full joint mobility (0/0/90°)
|
up to 7 days postoperatively
|
|
rescue pain medication
Time Frame: up to 7 days postoperatively
|
number of patients requiring rescue pain medication
|
up to 7 days postoperatively
|
|
time to discharge
Time Frame: up to 14 days postoperatively
|
time to discharge from hospital
|
up to 14 days postoperatively
|
|
time to first mobilisation (standing)
Time Frame: up to 48 hours postoperatively
|
time from end of surgery until patients is able to stand
|
up to 48 hours postoperatively
|
|
Janda grade of both legs at first day after surgery
Time Frame: up to 24h postoperatively
|
best Janda grade in both legs the day after surgery
|
up to 24h postoperatively
|
|
Pain intensity
Time Frame: up to 7 days postoperatively
|
intensity of pain in all patients meausered by numeric rating scale (NRS)
|
up to 7 days postoperatively
|
|
Opioid consumption (hospital)
Time Frame: up to 14 days postoperatively
|
amount of opioids administered until discharge measured as equivalent dose to morphin
|
up to 14 days postoperatively
|
|
delirium
Time Frame: up to 7 days postoperatively
|
incidence of postoperative delirium measured by Nursing Delirium Screening Scale (NuDeSc)
|
up to 7 days postoperatively
|
|
postoperative nausea and vomiting (PONV)
Time Frame: up to 7 days postoperatively
|
incidence of PONV
|
up to 7 days postoperatively
|
|
surgeon satisfaction (6-point likert scale)
Time Frame: intraoperative, up to 3 hours
|
satisfaction of surgeon in points of clarity of the operative field, change of the operative field by LIA and overall satisfaction represented in one value
|
intraoperative, up to 3 hours
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Morin AM, Wulf H. [High volume local infiltration analgesia (LIA) for total hip and knee arthroplasty: a brief review of the current status]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2011 Feb;46(2):84-6. doi: 10.1055/s-0031-1272875. Epub 2011 Feb 10. German.
- Perret M, Fletcher P, Firth L, Yates P. Comparison of patient outcomes in periarticular and intraarticular local anaesthetic infiltration techniques in total knee arthroplasty. J Orthop Surg Res. 2015 Jul 31;10:119. doi: 10.1186/s13018-015-0249-x.
- Peters CL, Shirley B, Erickson J. The effect of a new multimodal perioperative anesthetic regimen on postoperative pain, side effects, rehabilitation, and length of hospital stay after total joint arthroplasty. J Arthroplasty. 2006 Sep;21(6 Suppl 2):132-8. doi: 10.1016/j.arth.2006.04.017.
- Suthersan M, Pit S, Gordon L, Loman M, Pezzutti B, Freihaut R. Local infiltration analgesia versus standard analgesia in total knee arthroplasty. J Orthop Surg (Hong Kong). 2015 Aug;23(2):198-201. doi: 10.1177/230949901502300217.
- Kastelik J, Fuchs M, Kramer M, Trauzeddel RF, Ertmer M, von Roth P, Perka C, Kirschbaum SM, Tafelski S, Treskatsch S. Local infiltration anaesthesia versus sciatic nerve and adductor canal block for fast-track knee arthroplasty: A randomised controlled clinical trial. Eur J Anaesthesiol. 2019 Apr;36(4):255-263. doi: 10.1097/EJA.0000000000000929.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KneeOptOut2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.